Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

ACTON, Mass., March 24, 2022 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Kenneth Fisher, CPA, has joined the Company as Chief Financial Officer (CFO), effective March 23, 2022. He will report to Neil Dey, Chief Executive Officer. Gordon Kinder resigned his position as CFO to pursue other professional interests.

More details.

Share:

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/lmbric5/public_html/bluejaydx.com/wp-includes/functions.php on line 5221